Psychiatry Research
Volume 125, Issue 2 , Pages 117-127 , 15 February 2004

Potential sampling and recruitment source impacts in schizophrenia research

  • Carmel M Loughland

      Affiliations

    • Neuroscience Institute of Schizophrenia and Allied Disorders, The Garvan Institute, Darlinghurst, Sydney, NSW, 2001 Australia
    • Centre for Mental Health Studies, University of Newcastle and Hunter Mental Health, Callaghan, NSW, 2308 Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-2-4924-6611; fax: +61-2-4924-6608
    • ,
  • Vaughan J Carr

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle and Hunter Mental Health, Callaghan, NSW, 2308 Australia
    • ,
  • Terry J Lewin

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle and Hunter Mental Health, Callaghan, NSW, 2308 Australia
    • ,
  • Rosemary E Barnard

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle and Hunter Mental Health, Callaghan, NSW, 2308 Australia
    • ,
  • Jenny L Chapman

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle and Hunter Mental Health, Callaghan, NSW, 2308 Australia
    • ,
  • Jane M Walton

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle and Hunter Mental Health, Callaghan, NSW, 2308 Australia

Received 14 November 2002 ,Revised 6 November 2003 ,Accepted 28 November 2003.

References 

  1. Carr VJ, Lewin TJ, Barnard RE, Walton JM, Allen JL, Constable PM, et al. Comparisons between schizophrenia patients recruited from Australian general practices and public mental health services. Acta Psychiatrica Scandinavica. 2002;105:346–355
  2. Davies S, Thornicroft G, Leese M, Higgingbotham A, Phelan M. Ethnic differences in the risk of compulsory psychiatric admissions among representative cases of psychosis in London. British Medical Journal. 1996;312:533–537
  3. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin. 1998;24:443–445
  4. Goldstein JM, Seidman LJ, Goodman JM, Koren D, Lee H, Weintraub S, et al. Are there sex differences in neuropsychological functions among patients with schizophrenia?. American Journal of Psychiatry. 1998;155:1358–1362
  5. Hofer A, Hummer M, Huber R, Kurt M, Walch T, Fleischhacker WW. Selection bias in clinical trials with antipsychotics. Journal of Clinical Psychopharmacology. 2000;20:699–702
  6. Jablensky, A., McGrath, J., Herrman, H., Castle, D., Gureje, O., Morgan, V., Korten, A., 1999. People living with psychotic illness: an Australian study 1997–1998. National Survey of Mental Health and Wellbeing, Report 4. Mental Health Branch, Australian Commonwealth Department of Health and Aged Care, Canberra
  7. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, et al. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry. 2000;34:221–236
  8. Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B, et al. The National Psychiatric Morbidity Surveys of Great Britain—initial findings from the household survey. Psychological Medicine. 1997;27:775–789
  9. Kaiser W, Rriebe S, Barr W, Hoffmann K, Isermann M, Roder-Wanner V, et al. Profiles of subjective quality of life in schizophrenic in- and out-patient samples. Psychiatry Research. 1997;66:153–166
  10. Lang FH, Forbes JF, Murray GD, Johnstone EC. Service provision for people with schizophrenia. I. Clinical and economic perspective. British Journal of Psychiatry. 1997;171:159–164
  11. Lewine RRJ, Walker EF, Shurett R, Caudle J, Haden C. Sex differences in neuropsychological functioning among schizophrenia patients. American Journal of Psychiatry. 1996;153:1178–1184
  12. Loughland CM, Carr VJ, Lewin T. The NISAD schizophrenia research register: why do we need a schizophrenia research database?. Australian and New Zealand Journal of Psychiatry. 2001;35:660–667
  13. Nazareth I, King M, Davies S. Care of schizophrenia in general practice: the general practitioner and the patient. British Journal of General Practice. 1995;45:343–347
  14. Robinson D, Woerner MG, Pollack S, Lerner G. Subject selection biases in clinical trials—data from a multicenter schizophrenia treatment study. Journal of Clinical Psychopharmacology. 1996;16:170–176
  15. World Health Organization, 1988. WHO Psychiatric Disability Assessment Schedule (WHO/DAS). World Health Organization, Geneva

PII: S0165-1781(03)00296-8

doi: 10.1016/j.psychres.2003.11.002

Psychiatry Research
Volume 125, Issue 2 , Pages 117-127 , 15 February 2004

Article Tools

* Image Usage & Resolution